Dow Up 0.12% Nasdaq Up 0.03%

Idenix Pharmaceuticals Inc. (IDIX)

-NasdaqGS
24.50 Up 0.05(0.20%) Aug 5 - Nasdaq Real Time Price
Prev Close:24.50
Open:24.50
Bid:N/A
Ask:N/A
1y Target Est:21.50
Beta:0.82
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:24.46 - 24.50
52wk Range:2.93 - 24.50
Volume:5,087,160
Avg Vol (3m):2,814,090
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDIXUp 0.20%N/A
BMYDown 0.75%83.54B
GILDUp 1.28%162.71B
VRTXUp 0.01%22.30B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Sep-14) :N/A
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idenix Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of human viral diseases in the United States and France. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback